Healthpeak

Healthpeak Properties Announces $925 Million of Transaction Activity in South San Francisco

PhysiciansRealty

Goldman Sachs

Healthpeak: Goldman Sachs initiates Neutral coverage with $17 price target.

Navigating the Healthcare Landscape: Healthpeak Properties' Long-Term Prospects Amidst Industry Pressures

Investors Should Take Advantage of Goldman Sachs and Healthpeak Properties Now

Verizon

Realty Income

6 Ultra-High-Yield Dividend Stocks for Safe Income in 2026 and Beyond

Catalyst<ul> <li>A WR Oversold signal occurred multiple times in late December 2025 indicating potential for a rebound in DOC.</li></ul>Risk<ul> <li>The overall trend in technical indicators is weak and volatile suggesting caution for DOC.</li> <li>Fund flow analysis indicates a negative trend with small, medium and extra-large orders showing outflows.</li> <li>Fundamental analysis highlights several negative factors including asset and revenue relative to market value and cash growth concerns.</li> <li>Analyst ratings show a Neutral stance with market expectations leaning pessimistic for DOC.</li></ul>

Key Factors

Healthpeak Properties (DOC) is set to release Q4 2025 earnings on February 2, 2026, with attention on its monthly dividend strategy and capital recycling initiatives. DOC has announced $925 million in transaction activity, including a $600 million campus acquisition in South San Francisco and $325 million in outpatient medical facility dispositions.

Recent Updates

DOC News